Dr. Scott Gottlieb, a partner at one of the world's largest venture capital funds and a former deputy commissioner at the U.S. Food and Drug Administration, is being considered by President-elect Donald Trump to run the agency, according to sources close to the transition team.
Gottlieb, 44, a venture partner at New Enterprise Associates and resident fellow at the American Enterprise Institute, a conservative think tank based in Washington, is well known in health policy circles and is a frequent commentator on television and in print.
Gottlieb is being considered alongside Jim O'Neill, a self-declared libertarian and colleague of Peter Thiel, the co-founder of Mithril Capital Management who was an early Trump supporter and is now advising his transition team. Bloomberg News first reported that Trump was looking at O'Neill.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.